臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51201104 線上人數 : 796 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"ann lii cheng"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 361-370 / 690 (共69頁)
<< < 32 33 34 35 36 37 38 39 40 41 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-09-01T01:53:41Z	Helicobacter pylori sensitizes TNF-related apoptosisinducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIP	Lin W.-C.; Tsai H.-F.; Liao H.-J.; Tang C.-H.; Wu Y.-Y.; Hsu P.-I.; ANN-LII CHENG; Hsu P.-N.
臺大學術典藏	2021-09-01T01:53:40Z	Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based study	Lin C.-H.; Chuang P.-Y.; Chiang C.-J.; Lu Y.-S.; ANN-LII CHENG; Kuo W.-H.; Huang C.-S.; Lai M.-S.; You S.-L.; Tang C.-H.
臺大學術典藏	2021-09-01T01:53:40Z	Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study	Hsu C.; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:53:39Z	Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy	Chen J.L.-Y.; Huang C.-Y.; Huang Y.-S.; Chen R.-J.; Wang C.-W.; Chen Y.-H.; Cheng J.C.-H.; ANN-LII CHENG; Kuo S.-H.
臺大學術典藏	2021-08-31T06:42:28Z	�]-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma	Lu L.-C.; Shao Y.-Y.; Lee Y.-H.; Hsieh M.-S.; Hsiao C.-H.; Lin H.-H.; Kao H.-F.; Ma Y.-Y.; Yen F.-C.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-08-31T06:42:28Z	Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma	Liu W.-L.; Gao M.; Tzen K.-Y.; Tsai C.-L.; Hsu F.-M.; ANN-LII CHENG; Cheng J.C.-H.
臺大學術典藏	2021-08-31T06:42:27Z	A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors	Ghamande S.; Lin C.-C.; Cho D.C.; Shapiro G.I.; Kwak E.L.; Silverman M.H.; Tseng Y.; Kuo M.-W.; Mach W.B.; Hsu S.-C.; Coleman T.; Yang J.C.-H.; ANN-LII CHENG; Ghalib M.H.; Chuadhary I.; Goel S.
臺大學術典藏	2021-08-31T06:42:27Z	Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases	Shao Y.-Y.; Ho M.-C.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-08-31T06:42:27Z	Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer	Shen Y.-C.; Li C.-P.; Yen C.-J.; Hsu C.; Lin Y.-L.; Lin Z.-Z.; Chen L.-T.; Su W.-C.; Chao Y.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:42:27Z	Reply	Hsu C.; Chen P.-J.; ANN-LII CHENG

顯示項目 361-370 / 690 (共69頁)
<< < 32 33 34 35 36 37 38 39 40 41 > >>
每頁顯示[10|25|50]項目